Egetis Therapeutics AB Stock
Stocks
EGTX
SE0003815604
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.990 SEK | -1.27% |
|
+14.40% | +30.90% |
| Market Cap | 3.25B 343M 297M 277M 253M 477M 32.67B 485M 1.28B 16.34B 1.29B 1.26B 54.43B | P/E 2026 * |
476x | P/E 2027 * | -21.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.76B 291M 252M 235M 215M 405M 27.72B 411M 1.08B 13.87B 1.09B 1.07B 46.19B | EV / Sales 2026 * |
6.28x | EV / Sales 2027 * | 8.27x |
| Free-Float |
40.16% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Egetis Therapeutics AB
| 1 day | -1.27% | ||
| 1 week | +14.40% | ||
| Current month | +16.50% | ||
| 1 month | +14.97% | ||
| 3 months | +7.87% | ||
| 6 months | +35.20% | ||
| Current year | +30.90% |
| 1 week | 6.39 |  | 7.21 |
| 1 month | 5.86 | | 7.21 |
| Current year | 4.23 | | 7.21 |
| 1 year | 3.62 | | 7.21 |
| 3 years | 3.02 | | 9.3 |
| 5 years | 3 | | 9.3 |
| 10 years | 3 | | 50.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2017-06-15 | |
Yilmaz Mahshid
DFI | Director of Finance/CFO | 47 | 2017-12-30 |
Tiago Nune
CTO | Chief Tech/Sci/R&D Officer | - | 2026-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2016-12-31 | |
| Director/Board Member | 65 | 2016-12-31 | |
Mats Blom
CHM | Chairman | 61 | 2024-05-05 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/13/26 | Sell | Chief Executive Officer | -286,071 | 0.0724% | ||
| 5/11/26 | Fiscal year | Chief Financial Officer | 264,880 | 0.0670% | ||
| 1/16/26 | Buy | Chairman | 150,000 | 0.0380% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.27% | +14.40% | +20.93% | +57.79% | 343M | |
| +4.21% | +25.56% | +77.96% | +104.49% | 70.85B | |
| +0.50% | +6.20% | +34.94% | +67.83% | 55.41B | |
| +2.78% | +36.87% | +23.00% | +493.09% | 29.43B | |
| +1.78% | +18.87% | +57.08% | +5.18% | 24.12B | |
| -0.93% | +0.60% | -16.89% | -12.00% | 23.31B | |
| -0.35% | +7.91% | +44.14% | -22.61% | 18.37B | |
| +0.85% | +10.84% | +31.14% | +628.97% | 16.1B | |
| +7.26% | +14.16% | +221.03% | +393.89% | 16.99B | |
| -2.05% | -3.81% | +40.40% | +150.40% | 13.12B | |
| Average | +0.87% | +10.09% | +53.37% | +186.70% | 26.81B | |
| Weighted average by Cap. | +1.70% | +11.59% | +54.93% | +163.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 439M 46.24M 40.03M 37.42M 34.2M 64.44M 4.41B 65.45M 172M 2.21B 174M 170M 7.35B | 353M 37.17M 32.18M 30.08M 27.49M 51.81M 3.55B 52.62M 138M 1.77B 140M 137M 5.91B |
| Net income | 302M 31.87M 27.59M 25.79M 23.57M 44.41M 3.04B 45.11M 119M 1.52B 120M 117M 5.06B | -95.62M -10.08M -8.72M -8.15M -7.45M -14.04M -961M -14.26M -37.52M -481M -37.84M -37.01M -1.6B |
| Net Debt | -492M -51.88M -44.91M -41.98M -38.36M -72.29M -4.95B -73.42M -193M -2.48B -195M -191M -8.24B | -334M -35.21M -30.48M -28.49M -26.04M -49.06M -3.36B -49.83M -131M -1.68B -132M -129M -5.59B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-10 | SEK 6.990 | -1.27% | 1,121,387 |
| 26-08-07 | SEK 7.080 | +3.36% | 1,256,588 |
| 26-08-06 | SEK 6.850 | +1.63% | 731,610 |
| 26-08-05 | SEK 6.740 | +5.64% | 803,369 |
| 26-08-04 | SEK 6.380 | +4.42% | 844,845 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EGTX Stock
Select your edition
All financial news and data tailored to specific country editions
